Michael Scherz
Co-Founder, Head of Development
Argenica Therapeutics Ltd
SwitzerlandResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Dr. Michael Scherz is the Co-Founder and Head of Development at Arphamid Therapeutics GmbH in Switzerland. His research primarily focuses on pharmacological profiles and drug development, with a recent emphasis on MP-101, a novel non-racemic mixture aimed at enhancing cognitive function, alleviating depression, and addressing neuropathic pain in rat models. Dr. Scherz's contributions to the field demonstrate a commitment to advancing therapeutic approaches through innovative research methodologies.
Articles (1)
Year:
2022
Collaborators (1)
Lorenzo Di Cesare Mannelli
University of Florence
ITALY
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.